← All trials
NCT00908089
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 1, 2003
- Primary completion
- May 1, 2007
- Completion date
- Dec 1, 2015
- First posted
- —
- Last posted
- —
- Enrollment
- 100
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- University of HelsinkiLead sponsor
- University of TurkuStudy chair
- University of HelsinkiStudy director
- University of HelsinkiStudy chair
- Seinajoki Central HospitalCollaborator
- University of TurkuCollaborator
- Rheumatism Foundation HospitalCollaborator
- Government of FinlandCollaborator
- Central Hospital of Kanta-HameCollaborator
- Orton Invalid FoundationCollaborator
- Lappi Central HospitalCollaborator
- University of HelsinkiReponsible party - principal investigator
- University of OsloCollaborator
- Kuopio University HospitalStudy chair
- Kuopio University HospitalCollaborator
- University of TampereStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.